We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > liver diseases

News List

The Pharmacological Effects and Clinical Applications of Epipremnum Aureum in the Treatment of Liver Diseases Xiaomichong
July 05, 2024
Sedum sarmentosum, also known as trailing jade plant, hanging jade plant, or dogtooth half-branch, is the dried whole plant of Sedum sarmentosum, a member of the Crassulaceae family.
Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures firstwordpharma
June 17, 2021
Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, with participation from Backed VC, Apollo Health Ventures, Selvedge, Hoxton .
Takeda and HemoShear partner to discover new treatments for liver diseases pharmaceufical-technology
October 20, 2017
NASH is a serious, chronic liver disease characterised by inflammation and excessive fat accumulation in the liver, which may lead to fibrosis, cirrhosis, liver cancer and eventually liver failure.